Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1090220131Not yet recruiting
Randomised trial of rocuronium in None (2 arms), sponsored by Keiichi Nitahara. Primary endpoint: Onset time of rocuronium. Planned start Jul 2013; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1090220131.